Home Healthcare Pharmaceuticals Anti-Rheumatics Market

Anti-Rheumatics Market Size, Share & Trends Analysis Report By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others), By Type (Prescription-Based Drugs, Over-the-Counter Drugs) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format: | Report Code: SR5519DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Anti-Rheumatics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Disease Modifying Anti-Rheumatic Drugs
    2. Nonsteroidal Anti-inflammatory Drugs
    3. Corticosteroids
    4. Uric Acid Drugs
    5. Others
  2. Anti-Rheumatics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Prescription-Based Drugs
    2. Over-the-Counter Drugs
  3. Regional Anti-Rheumatics Market
    1. North America
      1. North America Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. North America Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. U.S. Anti-Rheumatics Market
        1. U.S. Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. U.S. Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      4. Canada Anti-Rheumatics Market
        1. Canada Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Canada Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
    2. Europe
      1. Europe Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. Europe Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. U.K. Anti-Rheumatics Market
        1. U.K. Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. U.K. Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      4. Germany Anti-Rheumatics Market
        1. Germany Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Germany Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      5. France Anti-Rheumatics Market
        1. France Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. France Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      6. Spain Anti-Rheumatics Market
        1. Spain Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Spain Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      7. Italy Anti-Rheumatics Market
        1. Italy Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Italy Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      8. Russia Anti-Rheumatics Market
        1. Russia Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Russia Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      9. Nordic Anti-Rheumatics Market
        1. Nordic Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Nordic Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      10. Benelux Anti-Rheumatics Market
        1. Benelux Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Benelux Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      11. Rest of Europe Anti-Rheumatics Market
        1. Rest of Europe Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Rest of Europe Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
    3. APAC
      1. APAC Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. APAC Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. China Anti-Rheumatics Market
        1. China Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. China Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      4. Korea Anti-Rheumatics Market
        1. Korea Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Korea Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      5. Japan Anti-Rheumatics Market
        1. Japan Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Japan Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      6. India Anti-Rheumatics Market
        1. India Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. India Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      7. Australia Anti-Rheumatics Market
        1. Australia Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Australia Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      8. Singapore Anti-Rheumatics Market
        1. Singapore Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Singapore Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      9. Taiwan Anti-Rheumatics Market
        1. Taiwan Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Taiwan Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      10. South East Asia Anti-Rheumatics Market
        1. South East Asia Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. South East Asia Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      11. Rest of Asia-Pacific Anti-Rheumatics Market
        1. Rest of Asia-Pacific Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Rest of Asia-Pacific Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
    4. Middle East and Africa
      1. Middle East and Africa Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. Middle East and Africa Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. UAE Anti-Rheumatics Market
        1. UAE Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. UAE Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      4. Turkey Anti-Rheumatics Market
        1. Turkey Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Turkey Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      5. Saudi Arabia Anti-Rheumatics Market
        1. Saudi Arabia Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Saudi Arabia Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      6. South Africa Anti-Rheumatics Market
        1. South Africa Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. South Africa Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      7. Egypt Anti-Rheumatics Market
        1. Egypt Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Egypt Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      8. Nigeria Anti-Rheumatics Market
        1. Nigeria Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Nigeria Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      9. Rest of MEA Anti-Rheumatics Market
        1. Rest of MEA Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Rest of MEA Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
    5. LATAM
      1. LATAM Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. LATAM Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. Brazil Anti-Rheumatics Market
        1. Brazil Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Brazil Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      4. Mexico Anti-Rheumatics Market
        1. Mexico Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Mexico Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      5. Argentina Anti-Rheumatics Market
        1. Argentina Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Argentina Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      6. Chile Anti-Rheumatics Market
        1. Chile Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Chile Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      7. Colombia Anti-Rheumatics Market
        1. Colombia Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Colombia Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
      8. Rest of LATAM Anti-Rheumatics Market
        1. Rest of LATAM Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Disease Modifying Anti-Rheumatic Drugs
          2. Nonsteroidal Anti-inflammatory Drugs
          3. Corticosteroids
          4. Uric Acid Drugs
          5. Others
        2. Rest of LATAM Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
          1. Prescription-Based Drugs
          2. Over-the-Counter Drugs
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.